Inactive Instrument

Insiders Momenta Pharmaceuticals, Inc.

Equities

MNTA

US60877T1007

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Momenta Pharmaceuticals, Inc. Announces Executive Changes	20-10-01	CI
Corey N. Fishman Not to Stand for Re-Election to Momenta Pharmaceuticals, Inc.'s Board of Directors	20-04-10	CI
Momenta Pharmaceuticals, Inc. Announces Management Changes	20-01-03	CI
Momenta Pharmaceuticals, Inc. Appoints Jane F. Barlow to Board of Directors	19-12-13	CI
Momenta Pharmaceuticals, Inc. Appoints Donna Grogan to its Board of Directors	19-09-19	CI
James R. Sulat to Retire as Director of Momenta Pharmaceuticals, Inc., Effective July 22, 2019	19-06-21	CI
Momenta Pharmaceuticals, Inc. Announces Executive Changes	18-05-08	CI
Momenta Pharmaceuticals, Inc. Promotes Ganesh V. Kaundinya as Chief Operating Officer	17-10-02	CI
Momenta Pharmaceuticals, Inc. Appoints Santiago Arroyo as Chief Medical Officer and Senior Vice President, Development	17-06-01	CI
Matthew P. Ottmer Will No Longer Serve as Chief Operating Officer of Momenta Pharmaceuticals, Inc., Effective May 1, 2017	17-05-01	CI
Marsha H. Fanucci Resigns from the Board of Directors of Momenta Pharmaceuticals, Inc. Effective December 31, 2016	16-12-21	CI
Momenta Pharmaceuticals Inc. Announces Executive Changes	16-11-02	CI
Momenta Pharmaceuticals Inc. Announces the Resignation of James M. Roach as Senior Vice President, Development and Chief Medical Officer, Effective on or Around November 29, 2016	16-10-19	CI
Momenta Pharmaceuticals Inc. Appoints Corey N. Fishman to its Board of Directors	16-09-23	CI
Momenta Pharmaceuticals Inc. Announces Board Changes	16-06-23	CI
Momenta Pharmaceuticals Inc. Appoints Jose-Carlos Gutierrez-Ramos, Ph.D. to Board of Directors	16-03-09	CI
John K. Clarke Retires from Board of Directors of Momenta Pharmaceuticals Inc., Effective December 31, 2015	15-12-14	CI
Momenta Pharmaceuticals, Inc. Appoints Matthew P. Ottmer as Chief Operating Officer	15-12-07	CI
Momenta Pharmaceuticals, Inc. Appoints Georges Gemayel to Board of Directors, Effective from January 1, 2016	15-09-18	CI
Momenta Pharmaceuticals Announces Executive Changes	15-06-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Momenta Pharmaceuticals, Inc.

Equities

MNTA

US60877T1007

Insiders

Filters